FDA Inspection 1301828 - Aspire Pharmaceuticals, Inc. - April 24, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Aspire Pharmaceuticals, Inc., with an inspection on April 24, 2026, issued by the New Jersey District Office, covering human drugs.

Company: Aspire Pharmaceuticals, Inc.
Inspection Date: April 24, 2026
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · c96eeeb1-09d0-4611-91fa-bf7a02d8e9bc

Violation Codes2

21 CFR 211.18221 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.